Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis–associated interstitial lung disease trials

被引：0
作者：
Dinesh Khanna
Vivek Nagaraja
Chi-hong Tseng
Fereidoun Abtin
Robert Suh
Grace Kim
Athol Wells
Daniel E. Furst
Philip J. Clements
Michael D. Roth
Donald P. Tashkin
Jonathan Goldin
机构：
[1] University of Michigan,University of Michigan Scleroderma Program, Division of Rheumatology, Department of Internal Medicine
[2] University of Toledo,Division of Rheumatology
[3] David Geffen School of Medicine at UCLA,Department of Biostatistics
[4] David Geffen School of Medicine at UCLA,Department of Radiology
[5] Royal Brompton Hospital,Division of Pulmonary and Critical Care
[6] David Geffen School of Medicine at UCLA,Department of Medicine
来源：
Arthritis Research & Therapy | / 17卷
关键词：
Systemic sclerosis; Interstitial lung disease; High-resolution computed tomography; Cohort enrichment; Randomized controlled trial; Scleroderma lung disease; Scleroderma Lung Study I (SLS I); Goh and Wells criteria;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 169 条
  • [1] Steen VD(2007)Changes in causes of death in systemic sclerosis, 1972–2002 Ann Rheum Dis. 66 940-944
  • [2] Medsger TA(2012)Interstitial lung disease: is interstitial lung disease the same as scleroderma lung disease? Curr Opin Rheumatol. 24 656-662
  • [3] Murray LA(2010)Recent advances in pulmonary fibrosis: implications for scleroderma Curr Opin Rheumatol. 22 683-689
  • [4] Rubinowitz A(2014)Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct? Arthritis Rheumatol. 66 1967-1978
  • [5] Herzog EL(2013)Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development Expert Rev Clin Immunol. 9 1077-1090
  • [6] Homer RJ(2014)Emerging cellular and molecular targets in fibrosis: implications for scleroderma pathogenesis and targeted therapy Curr Opin Rheumatol. 26 607-614
  • [7] Herzog EL(2002)Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome Am J Respir Crit Care Med. 165 1581-1586
  • [8] Herzog EL(1993)The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis Am Rev Respir Dis. 148 1076-1082
  • [9] Mathur A(1992)High resolution computed tomography as a predictor of lung histology in systemic sclerosis Thorax. 47 738-742
  • [10] Tager AM(2011)Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease Arthritis Rheum. 63 2797-2808
12345678910